Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition

Human Pathology

Volumn 40, Issue 10, 2009, Pages 1365-1376

  Guarino, Marcello ^a   Tosoni, Antonella ^b   Nebuloni, Manuela ^b  

^a DESIO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Epithelial mesenchymal transition; Fibrosis; Molecular pathways; Myofibroblasts; Pathogenesis; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CALVASCULIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN; FIBRONECTIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL PROLIFERATION; EPITHELIUM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; HUMAN; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; MESENCHYME; MESENCHYME CELL; MULTIPLE ORGAN FAILURE; MYOFIBROBLAST; OCULAR FIBROSIS; PARENCHYMA; PROTEIN DEPLETION; PROTEIN EXPRESSION; SEROSA; TISSUE REPAIR;

ANIMALS; CELL DIFFERENTIATION; EPITHELIUM; FIBROBLASTS; FIBROSIS; HUMANS; MESODERM;

EID: 69949124749     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.02.020     Document Type: Article

References (73)

1. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 10 (1995) 171-184
2. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112 (2003) 1776-1784
3. Neilson E.G. Plasticity, nuclear diapause, and a requiem for the terminal differentiation of epithelia. J Am Soc Nephrol 18 (2007) 1995-1998
4. Furness P.N. Extracellular matrix and the kidney. J Clin Pathol 49 (1996) 355-359
5. Desmoulière A., Darby I.A., and Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 83 (2003) 1689-1707
6. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214 (2008) 199-210
7. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117 (2007) 524-529
8. Moreira R.K. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 131 (2007) 1728-1734
9. Thannickal V.J., Toews G.B., White E.S., Lynch III J.P., and Martinez F.J. Mechanisms of pulmonary fibrosis. Annu Rev Med 55 (2004) 395-417
10. Eddy A.A. Molecular basis of renal fibrosis. Pediatr Nephrol 15 (2000) 290-301
11. Gressner O.A., Weiskirchen R., and Gressner A.M. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 6 (2007) 7
12. Flanders K.C. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85 (2004) 47-64
13. Strutz F., and Müller G.A. Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res 22 (1999) 71-80
14. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., and Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 170 (2007) 1807-1816
15. Zeisberg M., Maeshima Y., Mosterman B., and Kalluri R. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 160 (2002) 2001-2008
16. Kim K.K., Kugler M.C., Wolters P.J., et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103 (2006) 13180-13185
17. Gamulescu M.A., Chen Y., He S., et al. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 83 (2006) 212-222
18. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., and Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110 (2002) 341-350
19. Abe R., Donnelly S.C., Peng T., Bucala R., and Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 (2001) 7556-7562
20. Hay E.D. Interactions of embryonic cell surface and cytoskeleton with extracellular matrix. Am J Anat 165 (1982) 1-12
21. Nakaya Y., Sukowati E.W., Wu Y., and Sheng G. RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation. Nat Cell Biol 10 (2008) 765-775
22. Taneyhill L.A., Coles E.G., and Bronner-Fraser M. Snail2 directly represses cadherin6B during epithelial-to-mesenchymal transitions of the neural crest. Development 134 (2007) 1481-1490
23. Yusuf F., and Brand-Saberi B. The eventful somite: patterning, fate determination and cell division in the somite. Anat Embryol 211 Suppl 1 (2006) 21-30
24. Guarino M., Micheli P., Pallotti F., and Giordano F. Pathological relevance of epithelial and mesenchymal phenotype plasticity. Pathol Res Pract 195 (1999) 379-389
25. Böttinger E.P., and Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 13 (2002) 2600-2610
26. Yang J., and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159 (2001) 1465-1475
27. Okada H., Danoff T.M., Kalluri R., and Neilson E.G. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273 (1997) F563-F574
28. Peinado H., Portillo F., and Cano A. Switching on-off Snail: LOXL2 versus GSK3beta. Cell Cycle 4 (2005) 1749-1752
29. Sato M., Muragaki Y., Saika S., Roberts A.B., and Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112 (2003) 1486-1494
30. Masszi A., Di Ciano C., Sirokmány G., et al. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 284 (2003) F911-F924
31. Li Y., Yang J., Dai C., Wu C., and Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112 (2003) 503-516
32. Higgins D.F., Kimura K., Bernhardt W.M., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117 (2007) 3810-3820
33. Song J. EMT or apoptosis: a decision for TGF-beta. Cell Res 17 (2007) 289-290
34. Vega S., Morales A.V., Ocaña O.H., Valdés F., Fabregat I., and Nieto M.A. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18 (2000) 1131-1143
35. Rosen K., Shi W., Calabretta B., and Filmus J. Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J Biol Chem 277 (2002) 46123-46130
36. Choi Y.J., Chakraborty S., Nguyen V., et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 31 (2000) 1491-1497
37. Essawy M., Soylemezoglu O., Muchaneta-Kubara E.C., Shortland J., Brown C.B., and el Nahas A.M. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12 (1997) 43-50
38. Roberts I.S., Burrows C., Shanks J.H., Venning M., and McWilliam L.J. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 50 (1997) 123-127
39. Nadasdy T., Laszik Z., Blick K.E., Johnson D.L., and Silva F.G. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol 25 (1994) 22-28
40. Strutz F., Okada H., Lo C.W., et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130 (1995) 393-405
41. Cheng S., and Lovett D.H. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 162 (2003) 1937-1949
42. Cheng S., Pollock A.S., Mahimkar R., Olson J.L., and Lovett D.H. Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 20 (2006) 1898-1900
43. Strutz F., Zeisberg M., Ziyadeh F.N., et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61 (2002) 1714-1728
44. Rastaldi M.P., Ferrario F., Giardino L., et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62 (2002) 137-146
45. Boutet A., De Frutos C.A., Maxwell P.H., Mayol M.J., Romero J., and Nieto M.A. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25 (2006) 5603-5613
46. Nishitani Y., Iwano M., Yamaguchi Y., et al. Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int 68 (2005) 1078-1085
47. Bariety J., Hill G.S., Mandet C., et al. Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant 18 (2003) 1777-1784
48. Robertson H., Ali S., McDonnell B.J., Burt A.D., and Kirby J.A. Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15 (2004) 390-397
49. Hertig A., Anglicheau D., Verine J., et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 19 (2008) 1584-1591
50. Vongwiwatana A., Tasanarong A., Rayner D.C., Melk A., and Halloran P.F. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 5 (2005) 1367-1374
51. Noble P.W., and Homer R.J. Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 33 (2005) 113-120
52. Chilosi M., Poletti V., Zamò A., et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 162 (2003) 1495-1502
53. Willis B.C., Liebler J.M., Luby-Phelps K., et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166 (2005) 1321-1332
54. Koli K., Myllärniemi M., Vuorinen K., et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 169 (2006) 61-71
55. Ward C., Forrest I.A., Murphy D.M., et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 60 (2005) 865-871
56. Zeisberg M., Yang C., Martino M., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282 (2007) 23337-23347
57. Díaz R., Kim J.W., Hui J.J., et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 39 (2008) 102-115
58. Rygiel K.A., Robertson H., Marshall H.L., et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 88 (2008) 112-123
59. Robertson H., Kirby J.A., Yip W.W., Jones D.E., and Burt A.D. Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45 (2007) 977-981
60. Xia J.L., Dai C., Michalopoulos G.K., and Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168 (2006) 1500-1512
61. Saika S. TGFbeta pathobiology in the eye. Lab Invest 86 (2006) 106-115
62. Saika S., Miyamoto T., Ishida I., et al. TGFbeta-Smad signalling in postoperative human lens epithelial cells. Br J Ophthalmol 86 (2002) 1428-1433
63. Saika S., Kono-Saika S., Ohnishi Y., et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 164 (2004) 651-663
64. Seomun Y., Kim J., Lee E.H., and Joo C.K. Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells. Biochem J 358 (2001) 41-48
65. Casaroli-Marano R.P., Pagan R., and Vilaró S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40 (1999) 2062-2072
66. Kawaguchi M., Bader D.M., and Wilm B. Serosal mesothelium retains vasculogenic potential. Dev Dyn 236 (2007) 2973-2979
67. Mutsaers S.E. Mesothelial cells: their structure, function and role in serosal repair. Respirology 7 (2002) 171-191
68. Bolen J.W., Hammar S.P., and McNutt M.A. Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol 10 (1986) 34-47
69. Williams J.D., Craig K.J., Topley N., et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13 (2002) 470-479
70. Yáñez-Mó M., Lara-Pezzi E., Selgas R., et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348 (2003) 403-413
71. Jiménez-Heffernan J.A., Aguilera A., Aroeira L.S., et al. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch 444 (2004) 247-256
72. Margetts P.J., Bonniaud P., Liu L., et al. Transient overexpression of TGFβ-1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16 (2005) 425-436
73. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117 (2007) 539-548